A new method to heal severe burn wounds faster
An advanced dermal regeneration scaffold for skin loss due to burn wounds
This study is testing a new product called DermiSphere™ that helps heal severe burn injuries faster by creating a supportive layer for the skin, making it easier for your body to repair itself and recover more quickly.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fesariustherapeutics, INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11005669 on NIH RePORTER |
What this research studies
This research focuses on developing an advanced dermal regeneration scaffold designed to improve healing for patients with severe burn injuries. The innovative product, DermiSphere™, aims to recreate the dermis layer of the skin, allowing for quicker cellular infiltration and blood vessel formation, which are essential for effective healing. By using this scaffold, the goal is to significantly reduce the healing time for full thickness skin loss wounds compared to existing treatments. Patients will benefit from a more efficient healing process, potentially leading to better functional outcomes and reduced complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from large full thickness skin loss due to burn injuries.
Not a fit: Patients with minor burns or those whose wounds do not require dermal regeneration scaffolds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective healing of severe burn wounds, improving patient recovery and quality of life.
How similar studies have performed: Previous research has shown promise in using dermal replacement scaffolds for skin regeneration, but this approach with DermiSphere™ is innovative and aims to improve upon existing methods.
Where this research is happening
New York, United States
- Fesariustherapeutics, INC. — New York, United States (Active)
Researchers
- Principal investigator: Sapir Lekhovitser, Yulia — Fesariustherapeutics, INC.
- Study coordinator: Sapir Lekhovitser, Yulia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.